blockade of MAF oncogene expression A mechanistic rationale for MEK inhibitor therapy in myeloma based on
暂无分享,去创建一个
L. Staudt | R. Davis | A. Shaffer | E. Hurt | A. Zingone | L. Lamy | C. Annunziata | L. Hernandez | W. Kuehl
暂无分享,去创建一个
L. Staudt | R. Davis | A. Shaffer | E. Hurt | A. Zingone | L. Lamy | C. Annunziata | L. Hernandez | W. Kuehl